Bristol Myers Profile



Odds of Distress

Equity ratings for Bristol Myers Squibb Company are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting August 24, 2019 and ending today November 22, 2019. Click here to learn more.

Bristol Myers Profile

Next fiscal quarter end is expected on December 31, 2019. The stock is currently experiencing trading volume increase. Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. Bristol Myers operates under Drug Manufacturers - Major classification in USA and is traded on BATS Exchange. It employs 23300 people. more
Bristol Myers Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Bristol Myers Squibb SEC Filings
Bristol Myers SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameBristol Myers Squibb Company
ChairmanGiovanni CaforioView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 4 themes  View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Healthcare, Drug Manufacturers - General
InstrumentUSA Stock View All
RegionNorth America
LocationNew York; U.S.A
Business Address430 East 29th Street
Foreign Associate  Mexico
ExchangeBATS Exchange
CIK Number0000014272
IndustryDrug Manufacturers - Major
Phone212 546 4000
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterSeptember 30, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestOctober 31, 2019
Bristol Myers Squibb Company (BMY) is traded on BATS Exchange in USA. It is located in 430 East 29th Street and employs 23,300 people. Bristol Myers is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with total capitalization of 81.9 B. Bristol Myers Squibb runs under Healthcare sector within Drug Manufacturers - Major industry. The entity has 1.64 B outstanding shares of which 148.32 M shares are currently shorted by investors with about 12.13 days to cover shorted positions. BRISTOL MYERS SQI has about 29.36 B in cash with 4.29 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 17.95.
Check Bristol Myers Probability Of Bankruptcy

Ownership Allocation (%)

Bristol Myers Target Price Odds Analysis

Odds Below 56.48HorizonTargetOdds Above 56.48
87.49%30 days 56.48 12.41%
Based on normal probability distribution, the odds of Bristol Myers to move above current price in 30 days from now is about 12.41 (This Bristol Myers Squibb Company probability density function shows the probability of Bristol Myers Stock to fall within a particular range of prices over 30 days) .

Bristol Myers Squibb Top Holders

Bristol Myers Squibb Company Income Statement Over Time

Direct Expenses    Consolidated Income    Cost of Revenue    

Bristol Myers Key Fundamentals

Bristol Myers Against Markets

Did you try this?

Run Watchlist Optimization Now


Watchlist Optimization

Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
All  Next Launch Module

Bristol Myers Upcoming and Recent Events

Bristol Myers Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportJanuary 23, 2020
Next Earnings ReportApril 23, 2020
Next Fiscal Quarter EndDecember 31, 2019
Next Fiscal Year EndJanuary 23, 2020
Last Quarter Report DateSeptember 30, 2019
Last Earning Anouncement DateDecember 31, 2018

Bristol Myers Corporate Filings

Bristol Myers SEC Reporting

Financial Statements and Exhibits. Other Events
Submission of Matters to a Vote of Security Holders
Unclassified Corporate Event
Other Events

Bristol Myers Distributions to stockholders

Bristol Myers Corporate Directors

Togo West Independent Director
Karen Vousden Independent Director
Alan Lacy Independent Director
Check also Trending Equities. Please also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.